Roche's immune-boosting cancer drug Atezolizumab shrank tumor in patients with non-small-cell lung cancer in clinical trials. Bladder cancer patients with highest levels of PD-L1 also experienced tumor shrinkage.
New Drug Atezolizumab Shrinks Lung And Bladder Cancer Tumor Claims Roche
Tech Times - 29 Sep 2015 11:21
Roche's immune-boosting cancer drug Atezolizumab shrank tumor in patients with non-small-cell lung cancer in clinical trials. Bladder cancer patients with highest levels of PD-L1 also experienced tumor shrinkage.
Share this Article
Recommended